Coverage
-
February 19, 2016
A South Carolina federal judge freed AstraZeneca Pharmaceuticals LP from a medical school's patent infringement suit Friday over cholesterol drug Crestor, finding a university scientist's patent unenforceable because it was broad enough to be considered a hypothesis rather than an invention.
3 other articles on this case.
View all »